NCT01966172

Brief Summary

To test if multimodal analgesia with different analgesic medication offer better pain relief, lesser side effects and is safe compared to conventionel opiod analgesia after cardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2007

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2013

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 21, 2013

Completed
Last Updated

October 21, 2013

Status Verified

October 1, 2013

Enrollment Period

2.4 years

First QC Date

September 30, 2013

Last Update Submit

October 16, 2013

Conditions

Keywords

NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.

Outcome Measures

Primary Outcomes (1)

  • Evaluation of analgesic effect by 11-NRS scale

    assessement of analgesic effect for the first 4 days after surgery

    4th postoperative day

Secondary Outcomes (6)

  • Additional analgesic consumption

    4th postoperative day

  • Hospital stay in days.

    days until discharge

  • Evaluation of side-effects by daily questionnaire

    4th postoperative day

  • Cardiac complications

    30th postoperative day

  • Other complications

    30th postoperative day

  • +1 more secondary outcomes

Study Arms (2)

Multimodal

EXPERIMENTAL

oral Ibuprofen 400mg 4 times daily oral Gabapentin 300mg twice daily oral Paracetamol 1000mg 4 times daily

Drug: IbuprofenDrug: GabapentinDrug: Paracetamol

Morphine

ACTIVE COMPARATOR

oral Morphine 10mg 4 times daily oral paracetamol 1000mg 4 times daily

Drug: MorphineDrug: Paracetamol

Interventions

oral ibuprofen 400mg 4 times daily

Also known as: non-selective Non-steroid antiinflammatory drug (NSAID)
Multimodal

Oral Gabapentin 300mg twice daily

Multimodal

10 mg morphine orally 4 times daily

Also known as: An opiod
Morphine

oral paracetamol 1000mg four times daily

MorphineMultimodal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age\>18
  • any cardiac procedure with sternotomy
  • able to give informed consent

You may not qualify if:

  • cardiac surgery without sternotomy
  • peripheral neuropathy
  • neurological disease
  • psychiatric illness
  • history of GI bleeding
  • chronic pain (i.e. back pain, cancer, arthritis)
  • serum creatinine \>150 μmol/l
  • hepatic disease with elevated liver enzymes (SGPT and SGOT elevated to 1.5 times maximum normal value)
  • allergic to study medication
  • alcohol abuse
  • abuse of narcotics or medication
  • pregnancy
  • participation in other clinical trials
  • insufficient language skills

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet, Copenhagen University Hospital

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Rafiq S, Steinbruchel DA, Wanscher MJ, Andersen LW, Navne A, Lilleoer NB, Olsen PS. Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial. J Cardiothorac Surg. 2014 Mar 20;9:52. doi: 10.1186/1749-8090-9-52.

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Interventions

IbuprofenGabapentinMorphineAcetaminophen

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAminesgamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCyclohexanecarboxylic AcidsCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsAmino AcidsAmino Acids, Peptides, and ProteinsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAcetanilidesAnilidesAmidesAniline Compounds

Study Officials

  • Peter Skov Olsen, MD,PhD,DMSc

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR
  • Sulman Rafiq, MD

    Rigshospitalet, Denmark

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 30, 2013

First Posted

October 21, 2013

Study Start

March 1, 2007

Primary Completion

August 1, 2009

Study Completion

December 1, 2009

Last Updated

October 21, 2013

Record last verified: 2013-10

Locations